Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 12.320 | 12.320 | 0.000 |
Shares | 87.680 | 87.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.960 | 14.306 |
Price to Book | 3.105 | 1.991 |
Price to Sales | 2.107 | 1.337 |
Price to Cash Flow | 17.150 | 8.773 |
Dividend Yield | 2.698 | 3.278 |
5 Years Earnings Growth | 13.910 | 9.634 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 32.370 | 14.976 |
Financial Services | 18.710 | 17.234 |
Consumer Defensive | 14.470 | 11.544 |
Consumer Cyclical | 13.220 | 10.381 |
Industrials | 12.770 | 15.905 |
Technology | 4.290 | 9.506 |
Basic Materials | 4.180 | 6.970 |
Number of long holdings: 47
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.51 | 984.0 | +1.10% | |
AXA | FR0000120628 | 4.92 | 33.18 | -0.69% | |
L'Oreal | FR0000120321 | 4.16 | 455.35 | -0.18% | |
Siemens Healthineers | DE000SHL1006 | 3.64 | 55.10 | +0.07% | |
Intesa Sanpaolo | IT0000072618 | 3.47 | 3.5870 | -0.39% | |
Siemens AG | DE0007236101 | 3.45 | 174.44 | -0.71% | |
EssilorLuxottica | FR0000121667 | 3.43 | 208.80 | +0.48% | |
Beiersdorf AG | DE0005200000 | 3.21 | 145.050 | +1.47% | |
Novartis | CH0012005267 | 3.21 | 94.95 | -0.04% | |
Louis Vuitton | FR0000121014 | 3.11 | 762.50 | -0.03% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Generali Komfort Dynamik Europa | 1.39B | 7.43 | 4.57 | 4.76 | ||
LU1234787890 | 450.88M | 6.02 | 5.11 | - | ||
LU1234787205 | 450.88M | 5.93 | 4.85 | - | ||
LU1234787460 | 450.88M | 5.65 | 4.02 | - | ||
LU1234787544 | 450.88M | 5.40 | 3.30 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review